Category Archives: Generic drug

Bayer’s Indian appeal fails to block drug

Source: Trading Room DPA 15th December 2014 India’s Supreme Court has rejected German drug manufacturer Bayer AG’s plea to block production of a cheaper generic version of a patented cancer drug, in a ruling that ensures the medicine will be … Continue reading

Posted in access to medicines, Cancer, Compulsory Licensing, Drug Pricing, Generic drug | Leave a comment

Generic drug makers get a boost from SC ruling

Source: Hindu 14th December 2014 The Research and Development Centre of Natco Pharma, in Hyderabad. In a significant development for the pharmaceutical industry, the Supreme Court has rejected multinational Bayer’s appeal to block production and sales of the low cost … Continue reading

Posted in access to medicines, Cancer, Compulsory Licensing, Drug quality, Generic drug | Leave a comment

Let India Make Cheap Drugs

Source: NY Times NEW HAVEN, Conn. — Last month, the United States and India announced an important breakthrough concerning India’s “right-to-food” program. The Indian government subsidizes food for its poorest citizens through a system of price supports and public stockpiling. The … Continue reading

Posted in access to medicines, Drug Pricing, Generic drug, HIV/Aids, Intellectual Property, IP Rights, patent, Right to Health, WTO | Leave a comment

Indian Farmers, Trade Unions Slam RCEP Free Trade Talks

Source: Business World Activists say the RCEP free trade pact will damage Indian manufacturing, dairy and agriculture sectors India’s farmers, trade unions and civil society groups have expressed alarm  over the country’s participation in the 16-nation Regional Comprehensive Economic Partnership … Continue reading

Posted in access to medicines, FTAs, Generic drug, Regional Comprehensive Economic Partnership, Trans-Pacific Partnership Agreement, Transatlantic Trade and Investment Partnership (TTIP) | Tagged , | Leave a comment

Cipla-Novartis patent row: DIPP looking into merit of case

Source: Business Standard The Commerce and Industry Ministry is looking into the merit of Cipla’s demand for revocation of patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health access. The Department of Industrial … Continue reading

Posted in access to medicines, Generic drug, Indian Patent Law, IP Rights, Novartis Case, Revocation | Tagged , , | Leave a comment

EU pushing for a right to intercept medical products in transit

Source: Third World Network Geneva, 30 October (Chee Yoke Ling) – The European Union is pushing for a right to intercept and seize medical product shipments in transit on the way to final importing destinations, on the grounds of suspected … Continue reading

Posted in Generic drug, IPR Enforcement | Tagged , | Leave a comment

Indian generic drugs debate heats up

Source: The Lancet India has strongly objected to the findings of new research that raises questions about the quality of drugs manufactured in the country and exported abroad. Sanjeet Bagcchi reports. Findings from a new investigation have raised questions over … Continue reading

Posted in access to medicines, Drug quality, Drug regulation, Generic drug | Tagged , , , | Leave a comment